Both in Pharmaceuticals
Innoviva vs Pacira BioSciences
Over the past year INVA returned +17.7% and PCRX returned +64.2%; their daily moves had a correlation of 0.15.
INVA +17.7% PCRX +64.2%Growth of $1, one year, split-adjusted
| Metric | INVA | PCRX |
|---|---|---|
| Price | $21.32 | $36.43 |
| Market cap | $1.54B | $1.45B |
| Today | +1.84% | +0.10% |
| 1 month | +2.3% | +47.1% |
| 6 months | −5.4% | +53.8% |
| Year to date | +6.6% | +40.7% |
| 1 year | +17.7% | +64.2% |
| Revenue growth (YoY) | +19.3% | +6.2% |
| Gross margin | 81.3% | 77.0% |
| Net margin | −69.8% | 2.4% |
| P/E (TTM) | 4.3× | 99.3× |
| Price / sales | 3.5× | 1.9× |
| Net cash | $319.0M | -$112.1M |
| Dividend yield | — | — |
| Volatility (60d) | 21.2% | 78.5% |
| Short % of float | 10.5% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).